Caxton Associates (UK)’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.11M Buy
112,856
+63,952
+131% +$6.02M 0.15% 42
2026
Q1
$5.78M Buy
48,904
+31,646
+183% +$3.91M 0.13% 52
2025
Q4
$2.17M Buy
17,258
+14,417
+507% +$1.88M 0.04% 174
2025
Q3
$416K Buy
2,841
+28
+1% +$4.23K 0.01% 488
2025
Q2
$439K Sell
2,813
-2,834
-50% -$449K 0.01% 461
2025
Q1
$930K Buy
+5,647
New +$939K 0.03% 343

Other funds holding ZTS

Caxton Associates (UK)'s ZTS Position: Q2 2026 in Review

Caxton Associates (UK) increased its Zoetis (ZTS) stake by 131% in Q2 2026, buying an estimated $6.02M and bringing the position to 112,856 shares worth $8.11M. The position accounts for 0.15% of the portfolio, ranked #42.

Caxton Associates (UK) first reported a position in ZTS in Q1 2025 and has held it in 6 quarters since. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Caxton Associates (UK) held 112,856 shares of Zoetis worth $8.11M as of Q2 2026.
  • Caxton Associates (UK) bought 63,952 Zoetis shares in Q2 2026, an estimated $6.02M.
  • Zoetis made up 0.15% of Caxton Associates (UK)'s portfolio in Q2 2026, its #42 holding.
  • Caxton Associates (UK) first reported a position in Zoetis in Q1 2025 and has held it in 6 quarters since.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.